Medical Morphine Market, By Route of Administration (Oral, Parenteral, and Other routes (transdermal, suppository, intranasal, etc.)), By Application (Cancer related pain management, Acute pain (post surgery, trauma, myocardial infarction), Chronic pain (arthritis, musculoskeletal disorders), Palliative and end of life care, and Other applications (e.g., diarrhea suppression, cough suppression)), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare/Home Healthcare Settings, and Other (rehabilitation centers, hospices)), By Manufacturing Origin (Branded and Generic), By Strength (Low dose (e.g.≤10 mg), Medium dose (e.g.10 mg to ≤30 mg), and High dose (30 mg)), By Patient Age Group (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)